KYTX
Kyverna Therapeutics, Inc.
6.80$
-2.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | – | – | – | |
| 10.4% | 15.0% | – | – | – | |
| 100.0% | 100.0% | – | – | – | |
| 457.1% | 404.3% | – | – | – | |
| 108.7% | 114.0% | – | – | – | |
| 565.8% | 518.3% | – | – | – | |
| -465.8% | -418.3% | – | – | – | |
| 0.1% | 0.9% | – | – | – | |
| -465.9% | -411.3% | – | – | – | |
| 0.0% | 0.8% | – | – | – | |
| -465.9% | -411.3% | – | – | – | |
| -455.5% | -395.4% | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.